VACCINE AGAINST NEWCASTLE DISEASE

FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RAD'KOV VJACHESLAV NIKOLAEVICH, GRIGORENKO ARKADIJ IL'ICH, SHUL'GINA ZHANNA LEONIDOVNA, GOREVA IRINA PROKOF'EVNA, RUDENKO TAT'JANA VLADISLAVOVNA, SMOLENSKIJ VLADIMIR IVANOVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine; biotechnologies. ^ SUBSTANCE: vaccine contains virus material from "La-Sota" strain, saccharose, enzymatic peptone, casein, aerosil AM-1-300 and resin KB-4P-2. At that virus material from "La-Sota" strain used in vaccine is suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation. Vaccine also additionally contains alpha-tocopherol with the following ratio of components, wt %: suspension from whole hen's eggs with developed 12-13-day embryos infected with culture of "La-Sota" strain at 9-10 day of their incubation - 10.73-12.47, saccharose - 4.16-4.60, enzymatic peptone - 2.50-3.06, casein - 0.83-1.53, alpha-tocopherol - 0.04-0.08, aerosil AM-1-300 - 1.00-2.00, resin KB-4P-2 - the rest. ^ EFFECT: high immunogenicity, harmlessness for bird and ecological safety for servicing personnel. ^ 4 tbl, 5 ex